治疗新冠的药有哪几种药？

Recently, many people are asking what kind of drugs are there to treat COVID-19? There are currently 4 types of drugs known to treat COVID-19, namely Evusheld, nematvir/ritonavir (Paxlovid), monupivir/monoravir/molnupiravir, and ensitrelvir. At present, drugs for treating COVID-19 mainly include antiviral drugs, immunosuppressant drugs, antibacterial drugs, glucocorticoid drugs, antipyretic drugs, etc. However, the specific drug to be taken should be used under the guidance of a doctor and should not be used blindly to avoid affecting the original condition.

What are the effects of Evusheld, a drug used to treat COVID-19?

Evusheld is developed and produced by AstraZeneca and can be used for pre-exposure prophylaxis of COVID-19 (new coronavirus infection) in adults and adolescents aged 12 years and above weighing at least 40 kg; it can also be used to treat COVID-19 patients in adults and adolescents (12 years and above, weighing at least 40 kg) who do not require supplemental oxygen and are at increased risk of progression to severe COVID-19.

The current specifications are that each box contains 2 bottles: each bottle of tixagevimab contains 150 mg tixagevimab/1.5 mL (100 mg/mL). Each vial of cilgavimab contains 150 mg cilgavimab/1.5 mL (100 mg/mL).

It is reported that the price of the British AstraZeneca version of Evusheld is about $18,550 per box. The price is not fixed due to exchange rate fluctuations. Patients in need can obtain it through domestic professional overseas medical service institutions. It is cost-effective. For more details, please consult customer service personnel.

Evusheld for pre-exposure prophylaxis: The recommended dose for adults weighing at least 40 kg and adolescents 12 years and older is 150 mg tixagevimab and 150 mg cilgavimab given as two consecutive intramuscular injections. The recommended dose of Evusheld for the treatment of COVID-19 infection is 300 mg tixagevimab and 300 mg cilgavimab given as two consecutive intramuscular injections in adults weighing at least 40 kg and adolescents 12 years and older. Evusheld should be given as soon as possible after a positive test for the SARS-CoV-2 virus and within 7 days of the onset of COVID-19 symptoms.

Common side effects of Evusheld include headache, fatigue or cough. The overall safety profile is good and side effects are mild, with a few people reporting reactions or hypersensitivity at the injection site.

The effects of nematvir/ritonavir (Paxlovid), a drug used to treat COVID-19

Nematvir/ritonavir (Paxlovid) is an oral drug developed by Pfizer for the treatment of mild to moderate novel coronavirus (COVID-19) infection in adults with high risk factors for progression to severe disease. The specifications currently on the market are nematvir tablets 150mg/ritonavir tablets 100mg, packaged in aluminum-plastic blister packs. Each plate contains 4 nematvir tablets (pink) and 2 ritonavir tablets (white). 5 plates/box.

Currently, we know that the price in overseas markets is about $1,350 per box. Due to exchange rate fluctuations, drug prices are not fixed. Patients in need can obtain it through domestic professional overseas medical service organizations (such as Medical Companion Travel).

Nematasvir/Ritonavir Take Pfizer's special drug Nematasvir/Ritonavir (Paxlovid) as soon as possible within 5 days of COVID-19 diagnosis and the onset of symptoms. If a patient requires hospitalization due to severe or critical COVID-19 after starting treatment with this product, it is also recommended to complete 5 days of treatment. Nematvir 300 mg (150 mg × 2 tablets) combined with ritonavir 100 mg (100 mg × 1 tablet) is administered orally every 12 hours, that is, twice a day for 5 consecutive days. Pfizer's special drug nematvir tablets/ritonavir tablets (Paxlovid) need to be taken orally, and can be taken before or after meals.

Although Nematvir Tablets/Ritonavir Tablets (Paxlovid) have significant therapeutic effects, they also have side effects. Gastrointestinal diseases such as diarrhea, indigestion, gastroesophageal reflux disease, and vomiting may occur after taking the drug, as well as adverse reactions such as myalgia, taste disturbance, and dizziness. Pay attention to your body's reaction during medication. If you are intolerant, contact your doctor promptly for symptomatic treatment.

The effects of the drug monopiravir/monoravir (molnupiravir) used to treat COVID-19

Monupiravir/monoravir (molnupiravir) is developed and produced by Merck in the United States and can be used for infectious diseases caused by SARS-CoV-2 (patients infected with the new coronavirus). Currently, we know that the specifications on the market are 200 mg per pill; 40 pills/bottle.

It is understood that the price in overseas markets is about $350 per box, and the specifications are 200 mg per pill and 40 pills per bottle. However, the price is not fixed due to exchange rate fluctuations and can be obtained through overseas medical service organizations (such as Medical Companion Travel). Monopivir/monoravir is usually recommended for patients over 18 years of age, 800 mg twice a day, orally for 5 days. It is recommended that patients take medication as directed by their doctor and receive symptomatic treatment.

Generally speaking, after taking Monopivir/Monoravir, there will be no obvious side effects if used correctly according to the doctor's instructions. However, this medicine may cause side effects such as diarrhea, nausea, dizziness, and headache. Pay attention to your body's reaction during use. If you have intolerance, contact your doctor in time for symptomatic treatment.

The effects of Ensitrelvir, the drug used to treat COVID-19

Ensitrelvir is developed and produced by Japan's Shionogi. The specification is 125mg*28 tablets. It can be used to treat new coronavirus infection, even patients with mild symptoms who are at low risk of severe illness can take it.

The recommended usage and dosage of Ensitrelvir is 375 mg orally for children and adults over 12 years old on the first day, and 125 mg orally on the 2nd to 5th day, once a day. It is recommended that patients take medication as directed by their doctor and receive symptomatic treatment.

Although Ensitrelvir is effective in treating COVID-19 infection, it also has side effects. Common side effects include rash, nausea, vomiting, diarrhea, abdominal discomfort, headache, dyslipidemia, and increased serum iron. The patient should pay attention to the physical reaction during the medication. If there is any intolerance, contact the doctor in time for symptomatic treatment.

Which drug is more effective in treating COVID-19?

Evusheld, nematvir tablets/ritonavir tablets (Paxlovid), monupivir/monoravir/monabiravir (molnupiravir) and ensetrelvir (Ensitrelvir) are all drugs that can treat new coronavirus infection. However, different patients have different physiques, conditions, and drug absorption conditions, and the therapeutic effects after medication are also different. It is recommended that patients choose medications based on the doctor's diagnosis of the condition and not use them blindly. If you need COVID-19 drugs such as Evusheld, nematvir tablets/ritonavir tablets, monoprevir/monoravir, and ensetvir, you can obtain them through domestic professional overseas medical service organizations (such as Medical Companion Travel). For more details, please consult customer service personnel.

Recommended related articles: